Cover Image
市場調查報告書

乳房切片的全球市場 ∼2020年:各產品 (台、針、定位線、引導系統) 、類型、引導系統

Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020

出版商 MarketsandMarkets 商品編碼 337327
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
Back to Top
乳房切片的全球市場 ∼2020年:各產品 (台、針、定位線、引導系統) 、類型、引導系統 Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020
出版日期: 2015年07月24日 內容資訊: 英文 134 Pages
簡介

全球乳房切片市場,由於乳癌發生數量的增加,乳癌篩檢計劃數的增加,美國的乳房切片過程的新補償指南,及微創手術的需求擴大等,預計將促進發展,另一方面法規的問題以及乳房切片過程相關感染風險等要素,預見成為阻礙市場成長的要素。現在市場中液態切片的出現受到關注,以及預計今後新興國家成長。

本報告以全球乳房切片市場為主題,提供市場概要、市場發展促進、阻礙因素、市場上課題及機會、各產品 (台、針、定位線、引導系統) 、各類型 (開放式切片-切除、切口、針-核心針穿刺、真空補助) 、各引導系統 (超音波、定位、核磁共振攝影) 、各地區市場現況與展望相關調查分析、競爭環境、主要企業簡介彙整。

第1章 簡介

  • 調查的目的
  • 市場定義
  • 市場範圍
    • 網羅市場
    • 調查年份
  • 貨幣
  • 規定
  • 相關利益者

第2章 調查手法

  • 市場規模估計
  • 市場明細和資料的三角測量
    • 來自二級資訊來源的主要資料
    • 來自一級資訊來源的主要資料
    • 調查的前提條件

第3章 摘要整理

第4章 高級見解

  • 預測乳房切片市場穩定成長
  • 乳房切片市場,各引導系統
  • 乳房切片市場,各地區
  • 乳房切片市場,各產品
  • 針乳房切片市場
  • 生命週期分析,各地區

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 市場發展推動因素
      • 乳癌發生數量的增加
      • 乳癌篩檢計劃數的增加
      • 美國的乳房切片過程的新補償指南
      • 對微創手術的需求擴大
    • 市場發展阻礙因素
      • 法規的問題
      • 乳房切片過程相關感染風險
    • 市場機會
      • 新興國家的成長機會
    • 目前趨勢
      • 液態切片的出現

第6章 乳房切片市場,各產品

  • 簡介
  • 切片穿刺針
  • 引導系統
  • 切片檢查表格
  • 定位線
  • 其他

第7章 乳房切片市場,各類型

  • 簡介
  • 針乳房切片
    • 核心針切片檢查 (CNB)
    • 細微針穿刺切片檢查 (FNAB)
    • 真空補助下切片檢查 (VAB)
  • 開胸乳房切片
    • 切除乳房切片
    • 切口乳房切片

第8章 全球乳房切片市場,引導分類

  • 簡介
  • 乳房X光攝影誘導定位乳房切片
  • 超音波誘導乳房切片
  • 核磁共振攝影誘導乳房切片
  • 其他引導技術

第9章 乳房切片市場,各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞太地區 (APAC)
    • 中國
    • 印度
    • 其他亞太地區
  • 其他地區 (ROW)

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 新產品發表、認證
    • 收購
    • 產業擴張
    • 協定、夥伴關係、合作
    • 其他趨勢

第11章 企業簡介 (業績、產品與服務、主要策略、最近的動向)

  • 簡介
  • BECTON, DICKINSON AND COMPANY
  • C.R. BARD, INC.
  • DEVICOR MEDICAL PRODUCTS INC.
  • HOLOGIC INC.
  • ARGON MEDICAL DEVICES
  • COOK MEDICAL INCORPORATED
  • ENCAPSULE MEDICAL DEVICES LLC
  • ETHICON ENDO SURGERY (JOHNSON AND JOHNSON)
  • GALINI SRL
  • INTACT MEDICAL CORPORATION

第12章 附錄

  • 產業專家的觀點
  • 討論的指南
  • 其他趨勢
  • RT的介紹:即時 (RT) 市場資訊
  • 可能的客製化
  • 相關報告

圖表清單

目錄
Product Code: MD 3615

The report segments the breast biopsy market on the basis of products, types, guidance, and regions. On basis of products, the breast biopsy market is classified into biopsy needles, guidance systems, biopsy tables, localization wires, and others (markers, punches, sutures). The breast biopsy needles market is expected to account for largest share of the global breast biopsy needles market. The growth of the segment can be attributed to the increasing demand for needle biopsy.

Based on types, the market is categorized into needle and open surgical breast biopsy market. The needle breast biopsy market is subsegmented into core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB). Among these, the vacuum-assisted biopsy segment is expected to be fastest-growing segment. Growth can be attributed to the growing demand for less invasive breast biopsy procedures worldwide. The open surgical breast biopsy market is subsegmented into excisional and incisional breast biopsy.

Acquisition was the major strategy adopted by industry players. Emerging and immature markets such as Brazil, Argentina, Mexico, China, and India are lucrative markets for breast biopsy market, owing to the increasing incidences of breast cancer cases in these regions.

This research report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and the initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the breast biopsy market and their product portfolios, developments, and strategies adopted to maintain and increase their market shares. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the breast biopsy market. The report analyzes the breast biopsy market by product, type, guidance, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the breast biopsy market.
  • Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the breast biopsy market.
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various products across geographies
  • Market Diversification: Exhaustive information on new products and services, untapped geographies, recent developments, and investments in the breast biopsy market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key industry insights
    • 2.2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BREAST BIOPSY MARKET TO GROW AT A STEADY RATE
  • 4.2. BREAST BIOPSY MARKET, BY GUIDANCE SYSTEM
  • 4.3. BREAST BIOPSY MARKET, BY REGION
  • 4.4. BREAST BIOPSY MARKET, BY PRODUCT
  • 4.5. NEEDLE BREAST BIOPSY MARKET
  • 4.6. LIFECYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing incidence of breast cancer
      • 5.3.1.2. Increasing number of breast cancer screening programs
      • 5.3.1.3. New reimbursement guidelines for breast biopsy procedures in the U.S.
      • 5.3.1.4. Increasing demand for minimally invasive surgeries
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Regulatory issues
      • 5.3.2.2. Infection risks related to breast biopsy procedures
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Growth opportunities in emerging countries
    • 5.3.4. CURRENT TRENDS
      • 5.3.4.1. Emergence of liquid biopsy

6. BREAST BIOPSY MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. BIOPSY NEEDLES
  • 6.3. GUIDANCE SYSTEMS
  • 6.4. BIOPSY TABLES
  • 6.5. LOCALIZATION WIRES
  • 6.6. OTHERS

7. BREAST BIOPSY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. NEEDLE BREAST BIOPSY
    • 7.2.1. CORE-NEEDLE BIOPSY (CNB)
    • 7.2.2. FINE-NEEDLE ASPIRATION BIOPSY (FNAB)
    • 7.2.3. VACUUM-ASSISTED BIOPSY (VAB)
  • 7.3. OPEN SURGICAL BREAST BIOPSY
    • 7.3.1. EXCISIONAL BREAST BIOPSY
    • 7.3.2. INCISIONAL BREAST BIOPSY

8. GLOBAL BREAST BIOPSY MARKET, BY GUIDANCE

  • 8.1. INTRODUCTION
  • 8.2. MAMMOGRAPHY-GUIDED STEREOTACTIC BREAST BIOPSY
  • 8.3. ULTRASOUND-GUIDED BREAST BIOPSY
  • 8.4. MRI-GUIDED BREAST BIOPSY
  • 8.5. OTHER GUIDANCE TECHNIQUES

9. BREAST BIOPSY MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA-PACIFIC (APAC)
    • 9.4.1. CHINA
    • 9.4.2. INDIA
    • 9.4.3. REST OF ASIA-PACIFIC (ROAPAC)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES AND APPROVALS
    • 10.3.2. ACQUISITIONS
    • 10.3.3. EXPANSION
    • 10.3.4. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES

  • 11.1. INTRODUCTION
  • 11.2. BECTON, DICKINSON AND COMPANY
  • 11.3. C.R. BARD, INC.
  • 11.4. DEVICOR MEDICAL PRODUCTS INC.
  • 11.5. HOLOGIC INC.
  • 11.6. ARGON MEDICAL DEVICES
  • 11.7. COOK MEDICAL INCORPORATED
  • 11.8. ENCAPSULE MEDICAL DEVICES LLC
  • 11.9. ETHICON ENDO SURGERY (JOHNSON AND JOHNSON)
  • 11.10. GALINI SRL
  • 11.11. INTACT MEDICAL CORPORATION

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
    • 12.3.1. DEVICOR MEDICAL PRODUCTS INC.
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GROWING INCIDENCE OF BREAST CANCER TO DRIVE MARKET GROWTH
  • TABLE 2: INFECTION RISKS RELATED TO BREAST BIOPSY PROCEDURES TO RESTRAIN MARKET GROWTH
  • TABLE 3: EMERGING COUNTRIES TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 4: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 5: BREAST BIOPSY NEEDLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: BREAST BIOPSY GUIDANCE SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: BREAST BIOPSY TABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: LOCALIZATION WIRES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: OTHER BREAST BIOPSY PRODUCTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 11: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 12: NEEDLE BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: NORTH AMERICA: NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 14: ASIA-PACIFIC: NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: CORE-NEEDLE BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: NORTH AMERICA: CORE-NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: ASIA-PACIFIC: CORE-NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: FINE-NEEDLE ASPIRATION BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: FINE-NEEDLE ASPIRATION BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: ASIA-PACIFIC: FINE-NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: VACUUM-ASSISTED BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: NORTH AMERICA: VACUUM-ASSISTED BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: ASIA-PACIFIC: VACUUM-ASSISTED BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: EXCISIONAL BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: INCISIONAL BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 29: MAMMOGRAPHY GUIDANCE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: NORTH AMERICA: MAMMOGRAPHY GUIDANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: ASIA-PACIFIC: MAMMOGRAPHY GUIDANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: ULTRASOUND GUIDANCE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ULTRASOUND GUIDANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: ASIA-PACIFIC: ULTRASOUND GUIDANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 35: MRI GUIDANCE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: NORTH AMERICA: MRI GUIDANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC: MRI GUIDANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 38: OTHER GUIDANCE TECHNIQUES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: OTHER GUIDANCE TECHNIQUES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 40: ASIA-PACIFIC: OTHER GUIDANCE TECHNIQUES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 41: BREAST BIOPSY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 49: U.S.: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 51: CANADA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPE: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: CHINA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 63: CHINA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: INDIA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 65: INDIA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 69: ROW : OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: ROW: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 71: NEW PRODUCT LAUNCHES AND APPROVALS, 2013-2015
  • TABLE 72: ACQUISITIONS, 2013-2015
  • TABLE 73: EXPANSIONS, 2013-2015
  • TABLE 74: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2015
  • TABLE 75: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: BREAST BIOPSY MARKET
  • FIGURE 2: MARKET SIZE ESTIMATION
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: NEEDLE BREAST BIOPSY MARKET SNAPSHOT (2015 VS. 2020): VACUUM-ASSISTED BREAST BIOPSIES EXPECTED TO SHOW FASTEST GROWTH
  • FIGURE 6: MAMMOGRAPHY SEGMENT IS EXPECTED TO DOMINATE BREAST BIOPSY GUIDANCE SYSTEMS MARKET IN 2015
  • FIGURE 7: ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 8: BREAST BIOPSY GUIDANCE SYSTEMS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR
  • FIGURE 9: INCREASING INCIDENCES OF BREAST CANCER AND AWARENESS PROGRAMS TO DRIVE MARKET GROWTH
  • FIGURE 10: MAMMOGRAPHY SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE
  • FIGURE 11: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 12: BREAST BIOPSY GUIDANCE SYSTEMS SEGMENT EXPECTED TO BE THE FASTEST-GROWING MARKET
  • FIGURE 13: VACUUM-ASSISTED BIOPSY EXPECTED TO SHOW HIGHEST GROWTH
  • FIGURE 14: ASIA-PACIFIC MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 15: BREAST BIOPSY MARKET SEGMENTATION
  • FIGURE 16: BREAST BIOPSY MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 17: BREAST CANCER: GLOBAL INCIDENCE AND MORTALITY AMONG WOMEN
  • FIGURE 18: NEEDLES PRODUCT SEGMENT TO DOMINATE BREAST PRODUCT MARKET IN 2015
  • FIGURE 19: APAC IS EXPECTED TO BE THE FASTEST-GROWING REGION IN THE BIOPSY NEEDLES MARKET (2015-2020)
  • FIGURE 20: NORTH AMERICA IS EXPECTED TO DOMINATE THE GUIDANCE SYSTEMS MARKET (2015)
  • FIGURE 21: EUROPE IS EXPECTED TO BE THE SECOND-LARGEST SEGMENT OF THE BIOPSY TABLES MARKET
  • FIGURE 22: EUROPE IS EXPECTED TO BE THE SECOND LARGEST SEGMENT OF THE LOCALIZATION WIRES MARKET
  • FIGURE 23: APAC MARKET FOR OTHER PRODUCTS EXPECTED TO SHOW FASTEST GROWTH
  • FIGURE 24: NEEDLE BREAST BIOPSY IS EXPECTED TO DOMINATE THE BREAST BIOPSY TYPE MARKET IN 2015
  • FIGURE 25: CORE-NEEDLE BIOPSY IS EXPECTED TO DOMINATE THE NEEDLE BREAST BIOPSY MARKET IN 2015
  • FIGURE 26: NORTH AMERICA EXPECTED TO DOMINATE THE NEEDLE BREAST BIOPSY MARKET IN 2015
  • FIGURE 27: ASIA-PACIFIC EXPECTED TO BE THE FASTEST-GROWING SEGMENT OF THE CORE-NEEDLE BIOPSY MARKET
  • FIGURE 28: NORTH AMERICA IS EXPECTED TO DOMINATE THE FINE-NEEDLE ASPIRATION BIOPSY MARKET IN 2015
  • FIGURE 29: ASIA-PACIFIC EXPECTED TO BE THE FASTEST-GROWING SEGMENT OF THE VACUUM-ASSISTED BIOPSY MARKET (2015- 2020)
  • FIGURE 30: EXCISIONAL BREAST BIOPSY EXPECTED TO BE THE FASTEST-GROWING SEGMENT IN THE OPEN SURGICAL BIOPSY MARKET (2015-2020)
  • FIGURE 31: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OPEN SURGICAL BREAST BIOPSY MARKET
  • FIGURE 32: MAMMOGRAPHY IS EXPECTED TO DOMINATE THE BREAST BIOPSY GUIDANCE MARKET IN 2015
  • FIGURE 33: MAMMOGRAPHY GUIDANCE MARKET TO WITNESS THE HIGHEST GROWTH IN THE ASIA-PACIFIC REGION
  • FIGURE 34: NORTH AMERICA IS EXPECTED TO DOMINATE THE ULTRASOUND GUIDANCE MARKET IN 2015
  • FIGURE 35: ASIA-PACIFIC IS EXPECTED TO BE THE FASTEST-GROWING MARKET FOR MRI GUIDANCE
  • FIGURE 36: NORTH AMERICA IS EXPECTED TO DOMINATE THE OTHER GUIDANCE TECHNIQUES MARKET IN 2015
  • FIGURE 37: GEOGRAPHIC SNAPSHOT (2015): ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 38: ASIA-PACIFIC: AN ATTRACTIVE DESTINATION FOR ALL PRODUCT CATEGORIES
  • FIGURE 39: NORTH AMERICA IS EXPECTED TO DOMINATE THE BREAST BIOPSY MARKET (2015)
  • FIGURE 40: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE IN THE BREAST BIOPSY MARKET (2015)
  • FIGURE 41: ULTRASOUND SEGMENT TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN BREAST BIOPSY MARKET (2015-2020)
  • FIGURE 42: NEEDLE BREAST BIOPSY EXPECTED TO BE LARGEST AND FASTEST-GROWING SEGMENT IN THE BREAST BIOPSY MARKET IN NORTH AMERICA (2015-2020)
  • FIGURE 43: CORE-NEEDLE BIOPSY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN THE NORTH AMERICAN NEEDLE BREAST BIOPSY MARKET (2015)
  • FIGURE 44: NEEDLES EXPECTED TO COMMAND THE LARGEST SHARE IN THE BREAST BIOPSY PRODUCTS MARKET IN NORTH AMERICA (2015)
  • FIGURE 45: NEEDLE BREAST BIOPSY TO COMMAND THE LARGEST SHARE IN THE BREAST BIOPSY MARKET IN EUROPE (2015)
  • FIGURE 46: VACUUM-ASSISTED BIOPSY EXPECTED TO BE FASTEST-GROWING SEGMENT IN IN THE EUROPEAN NEEDLE BIOPSY MARKET (2015-2020)
  • FIGURE 47: GUIDANCE SYSTEMS EXPECTED TO BE FASTEST-GROWING SEGMENT IN THE BREAST BIOPSY PRODUCTS MARKET IN EUROPE (2015-2020)
  • FIGURE 48: ASIA-PACIFIC EXPECTED TO BE FASTEST-GROWING SEGMENT IN THE GLOBAL BREAST BIOPSY MARKET (2015-2020)
  • FIGURE 49: NEEDLE BREAST BIOPSY SEGMENT TO GROW AT THE HIGHER CAGR IN THE FORECAST PERIOD
  • FIGURE 50: CORE-NEEDLE BIOPSY TO DOMINATE THE NEEDLE BREAST BIOPSY MARKET IN APAC (2015)
  • FIGURE 51: MAMMOGRAPHY TO DOMINATE THE APAC NEEDLE BREAST BIOPSY MARKET (2015)
  • FIGURE 52: GUIDANCE SYSTEMS TO BE THE FASTEST-GROWING SEGMENT IN THE APAC BREAST BIOPSY PRODUCTS MARKET (2015-2020)
  • FIGURE 53: ULTRASOUND TO BE THE FASTEST-GROWING SEGMENT IN THE MARKET IN CHINA (2015-2020)
  • FIGURE 54: MAMMOGRAPHY SEGMENT TO DOMINATE THE BREAST BIOPSY MARKET IN INDIA (2015)
  • FIGURE 55: MAMMOGRAPHY SEGMENT EXPECTED TO DOMINATE THE ROW BREAST BIOPSY MARKET (2015)
  • FIGURE 56: NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE THE ROW BREAST BIOPSY MARKET (2015)
  • FIGURE 57: NEEDLES SEGMENT IS EXPECTED TO DOMINATE THE ROW BREAST BIOPSY PRODUCTS MARKET (2015)
  • FIGURE 58: COMPANIES ADOPTED NEW PRODUCT LAUNCHES AND APPROVALS AS THEIR KEY GROWTH STRATEGY (2012 - 2015)
  • FIGURE 59: GLOBAL BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 60: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 61: C.R. BARD, INC.: COMPANY SNAPSHOT
  • FIGURE 62: ETHICON ENDO SURGERY (JOHNSON AND JOHNSON): COMPANY SNAPSHOT
Back to Top